Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function
Author:
Affiliation:
1. Emory Transplant Center; Emory University; Atlanta GA
2. School of Public Health; Emory University; Atlanta GA
3. Renal Division; Department of Medicine; Emory University; Atlanta GA
4. Department of Surgery; Duke University; Durham NC
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14353/fullpdf
Reference26 articles.
1. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant;Wolfe;N Engl J Med,1999
2. Systematic review: Kidney transplantation compared with dialysis in clinically relevant outcomes;Tonelli;Am J Transplant,2011
3. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era;Meier-Kriesche;Am J Transplant,2004
4. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies?;Meier-Kriesche;Am J Transplant,2004
5. Kidney;Hart;Am J Transplant,2016
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation;American Journal of Transplantation;2024-02
2. Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte counts;Transplant Immunology;2024-02
3. New immunosuppressive protocols in living donor organ transplantation;Living Donor Organ Transplantation;2024
4. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024
5. Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future;Kidney International Reports;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3